GLP‑1 and bloating: possible causes and what may help

Introduction

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can cause bloating or abdominal distension. Adult Wegovy injection trials reported abdominal distension in 7% of participants taking Wegovy and 5% taking placebo. These figures are specific to Wegovy trials; rates can differ by medicine, dose, and study. 1 2

Why bloating may happen

Semaglutide and tirzepatide can slow stomach emptying and cause other gastrointestinal symptoms. This can contribute to fullness or distension, but bloating has many possible causes. 1 2 3 The symptom alone does not show that food is fermenting or that a particular food is responsible.

Steps that may help

Notice whether smaller portions, slower eating, or avoiding certain foods helps. Stop eating when you feel full and stay upright if reflux occurs. Avoid eliminating nutritious foods unless a clinician advises you to. Ask your clinician or pharmacist before trying an over-the-counter medicine or supplement.

If bloating began after a dose increase, persists, or affects eating and drinking, discuss it with your prescriber. Do not adjust your dose without medical guidance.

When to seek urgent care

Severe or persistent abdominal pain, a swollen abdomen with repeated vomiting, or inability to pass stool or gas needs urgent medical assessment. Contact your provider for worsening symptoms, repeated vomiting, or signs of dehydration. 2 4

Track symptoms with Shotsy

Use Shotsy notes to record bloating, meals, bowel changes, and dose timing. A clear history may help your clinician assess possible causes.

Conclusion

Bloating can occur during GLP‑1 treatment, but no single cause or trigger explains it for everyone. Speak with your clinician if bloating persists or worsens. Seek urgent care for severe pain, vomiting with abdominal swelling, or inability to pass stool or gas.